– UK, Crawley – Inspiration Healthcare Group plc (LON: IHC), the global medical technology company pioneering best-in-class, specialist neonatal intensive care medical devices, today announced the appointment of Roy Davis to its Board as a Non-Executive Director effective from 25 January 2024, to succeed Mark Abrahams as Chair of the Board of Directors from 21 March 2024, when Mark Abrahams will step down from the Board.
Roy Davis will also join the Nominations Committee, to succeed Mark Abrahams as Chair of this Committee.
About Gordon Roy Davis
Roy Davis brings a wealth of commercial experience in medical device companies and has a proven track record of successfully scaling companies and delivering substantial value for shareholders. He has held leadership positions at several publicly quoted med tech companies, including CEO of Optos plc, a leading retinal imaging device manufacturer, from 2008 to 2016 until its sale to Nikon for £259m in February 2015. From 2007 to 2008, Roy was CEO of Gyrus Group plc, a leader in minimally invasive surgery and visualization, until its acquisition by Olympus Corporation in 2008 for $1.9 billion.
He is currently Non-Executive Chair at LungLife AI plc, Foster and Freeman (the trading name of the Galton group of companies), and Rair Health Ltd and was until recently, Non-Executive Chair at Medica Group plc until its acquisition by IK Partners for £269 million earlier this year.
Roy Davis said: “I am delighted to be joining the Board of Inspiration Healthcare. The Company is addressing a critical need, providing innovative, lifesaving neonatal technologies and has the right products and expertise to deliver significant long-term sustainable growth. I look forward to working with Neil, the Executive team and the rest of the Board in executing the strategy and delivering the next stage of the Company’s development.”
About Inspiration Healthcare
Inspiration Healthcare designs, manufactures, and markets pioneering medical technology. Based in the UK, the Company specializes in neonatal intensive care medical devices, which address a critical need to help to save lives and improve the outcomes of patients, starting with the very first breaths of life.
The Company has a broad portfolio of its own products and complementary distributed products, for use in neonatal intensive care designed to support even the most premature babies throughout their hospital stay. Its own branded products range from highly sophisticated capital equipment such as ventilators for life support to single-use disposables.
The Company sells its products directly to hospitals and healthcare providers in the UK and Ireland, where it also distributes a range of advanced medical technologies for infusion therapy. In the rest of the world, the Company has an established network of distribution partners around the world giving access to more than 75 countries.
The Company operates from its world-class Manufacturing and Technology Centre in Croydon, South London, and its facility in Hailsham, East Sussex.
For more information: https://www.inspiration-healthcare.com/
- Disclaimer - News, data, and statements included in this release are intended exclusively for general information purposes. Talent4Boards does not guarantee that news is accurate or about the correct person and accepts neither liability for the consequences of the reader’s reliance, nor responsibility for the accuracy of the information. Nothing in this release should be considered for decisions about referred securities. Products and brand names may be trademarks or registered trademarks of their respective owners.
